23,581 Shares in Koninklijke Philips N.V. $PHG Bought by Greenleaf Trust

Greenleaf Trust bought a new position in shares of Koninklijke Philips N.V. (NYSE:PHG) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 23,581 shares of the technology company’s stock, valued at approximately $641,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Legacy Wealth Asset Management LLC raised its position in shares of Koninklijke Philips by 13.8% during the second quarter. Legacy Wealth Asset Management LLC now owns 81,715 shares of the technology company’s stock worth $2,222,000 after acquiring an additional 9,938 shares during the last quarter. Trust Point Inc. raised its holdings in Koninklijke Philips by 10.3% during the 2nd quarter. Trust Point Inc. now owns 9,236 shares of the technology company’s stock worth $251,000 after purchasing an additional 864 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Koninklijke Philips by 69.6% in the 2nd quarter. GAMMA Investing LLC now owns 29,761 shares of the technology company’s stock worth $809,000 after purchasing an additional 12,212 shares during the period. Versant Capital Management Inc boosted its stake in shares of Koninklijke Philips by 19.7% in the 2nd quarter. Versant Capital Management Inc now owns 15,108 shares of the technology company’s stock valued at $411,000 after purchasing an additional 2,483 shares during the last quarter. Finally, Bank of America Corp DE increased its position in shares of Koninklijke Philips by 7.7% during the first quarter. Bank of America Corp DE now owns 700,141 shares of the technology company’s stock worth $19,184,000 after buying an additional 50,124 shares during the period. Institutional investors own 13.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on PHG. Weiss Ratings raised shares of Koninklijke Philips from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. UBS Group reissued a “neutral” rating on shares of Koninklijke Philips in a research note on Monday, August 3rd. Finally, Zacks Research upgraded Koninklijke Philips from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 13th. Five equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Koninklijke Philips has a consensus rating of “Hold”.

Koninklijke Philips Stock Performance

NYSE:PHG opened at $26.58 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 1.26 and a debt-to-equity ratio of 0.55. Koninklijke Philips N.V. has a twelve month low of $23.85 and a twelve month high of $33.44. The company has a fifty day moving average of $26.92 and a 200-day moving average of $27.51. The firm has a market capitalization of $26.13 billion, a P/E ratio of 19.59, a P/E/G ratio of 11.02 and a beta of 0.76.

Koninklijke Philips (NYSE:PHG) last issued its earnings results on Monday, July 27th. The technology company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.17. The business had revenue of $4.98 billion for the quarter, compared to analyst estimates of $4.91 billion. Koninklijke Philips had a net margin of 6.30% and a return on equity of 14.38%. Koninklijke Philips’s revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.27 earnings per share. As a group, sell-side analysts anticipate that Koninklijke Philips N.V. will post 1.75 EPS for the current year.

About Koninklijke Philips

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.